BIO-TECHNE Corp Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIO-TECHNE Corp stock issued during period, value, restricted stock award, gross for fiscal 2024 was -$5.34M.
- BIO-TECHNE Corp stock issued during period, value, restricted stock award, gross for fiscal 2023 was -$6.73M.
- BIO-TECHNE Corp stock issued during period, value, restricted stock award, gross for fiscal 2022 was -$9.98M.
- BIO-TECHNE Corp stock issued during period, value, restricted stock award, gross for fiscal 2021 was -$7.06M.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2024-06-30 | -$5.34M 10-K · filed 2024-08-22 | |
| 2023-06-30 | -$6.73M 10-K · filed 2024-08-22 | |
| 2022-06-30 | -$9.98M 10-K · filed 2024-08-22 | |
| 2021-06-30 | -$7.06M 10-K · filed 2023-08-23 | |
| 2020-06-30 | -$2.23M 10-K · filed 2022-08-24 | |
| 2019-06-30 | -$2.58M 10-K · filed 2021-08-25 | |
| 2018-06-30 | -$273.00K 10-K · filed 2020-08-26 | |
| 2017-06-30 | -$287.00K 10-K/A · filed 2019-11-06 | |
| 2016-06-30 | -$167.00K 10-K · filed 2018-08-27 | |
| 2015-06-30 | -$57.00K 10-K · filed 2017-09-07 | |
| 2014-06-30 | $0.00 10-K · filed 2016-08-29 | |
| 2013-06-30 | $0.00 10-K · filed 2015-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |